(4-Methoxypyrimidin-2-yl)methanamine(909563-18-4)
- Name: (4-Methoxypyrimidin-2-yl)methanamine
- Synonyms:(4-Methoxypyrimidin-2-yl)methanamine;909563-18-4;MFCD10697249;2-Pyrimidinemethanamine, 4-methoxy-;4-Methoxypyrimidine-2-methanamine;SCHEMBL3511885;NDBSWKMPQRFLQA-UHFFFAOYSA-N;SB15618;AS-50722;SY143333;CS-0056594;EN300-104716;P10963
- Molecular Formula:C6H9N3O
- Molecular Weight:139.16
- CAS Registry Number:909563-18-4
- EINECS:861-957-5
- Melting Point:
- Water Solubility:
CAS No.909563-18-4 (4-Methoxypyrimidin-2-yl)methanamine
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.909563-18-4 (4-Methoxypyrimidin-2-yl)methanamine
Assay:NLT 98% Appearance:White powder Package:Aluminum bag/Carton Drum Storage:Store in a tightly closed container, in a cool and dry place. Transportation:By air Application:Used in producing API
Min. Order:0
Supplier:Hangzhou Huarong Pharm Co., Ltd. [
China (Mainland)] CAS No.909563-18-4 (4-Methoxypyrimidin-2-yl)methanamine;909563-18-4
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]
Other Product
- 1219967-45-9/Ethyl 3-amino-4-(2,3-dihydro-1H-indol-1-yl)-benzoate
- 80097-75-2/(1R,2S,4R,8S,9S,12S,13R)-8-acetyl-6,6,9,13-tetramethyl-19-methylidene-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one
- 944905-36-6/5-Fluorospiro[indoline-3,4'-piperidine]
- 646504-80-5/6-Bromo-7-methylquinoxaline
- 763109-74-6/5-(4-(Methylthio)phenyl)isoxazole-3-carboxylic acid
- 37992-15-7/7-Bromo-2-ethyl-2,3-dihydroimidazo[1,2-f]phenanthridine--hydrogen bromide (1/1)
- 18110-40-2/2-Amino-2-phenylpropan-1-ol hydrochloride
- 1306739-92-3/4-Cyclohex-3-en-1-yl-1,4-dihydro[1,3,5]triazino[1,2-a]benzimidazol-2-amine
- 1385694-53-0/1-(3-Bromophenyl)-4-oxocyclohexanecarboxylic acid
- 310451-79-7/3-[(4-Fluorophenyl)thio]-5-nitroaniline
- 121346-33-6/N-(3,4-Dimethoxyphenethyl)-3-(4-((3-isopropyl-1-methyl-1H-indol-2-yl)sulfonyl)phenoxy)-N-methylpropan-1-amine oxalate
- 102190-55-6/28-Oxo ivermectin B1a impurity
- 617715-95-4/2-Methylcyclopropane-1-carboximidamide hydrochloride
- 1400645-21-7/N-(3-Bromo-5-trifluoromethylphenyl)-1,3-propanesultam
- 1638744-05-4/cis-Tert-butyl 3-amino-2-methylpiperidine-1-carboxylate
- 1060801-67-3/6-Chloro-5-methoxypyridine-3-carbaldehyde
- 1174657-07-8/Cilastatin ep impurity E
- 1119449-74-9/3-{[(4-amino-4H-1,2,4-triazol-3-yl)thio]methyl}-4-methoxybenzaldehyde
- 120991-47-1/1,2,3,4-Tetrabromo-5-(2,5-dibromophenyl)benzene
- 909563-18-4/(4-Methoxypyrimidin-2-yl)methanamine
- 949080-24-4/3,5-Seco-4-norcholestan-5-one oxmie-3-ol
- 1419101-32-8/5-Methylpyrimidine-2-carboxamidine hydrochloride
- 1707365-44-3/2-Bromo-4-(4,4-difluoropiperidin-1-yl)nitrobenzene
- 125534-16-9/7-(6-Butoxy-5-methyl-2H-benzotriazol-2-yl)-3-phenyl-2H-1-benzopyran-2-one
- 1257553-86-8/3-Cyclobutoxy-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridine
- 1261983-86-1/3-Cyano-5-(2,5-dichlorophenyl)phenol
- 1269292-10-5/Ethanethioic acid, S-(cyclopropylmethyl) ester
- 1363380-61-3/6-Bromo-2-methyl-2H-indazole-3-sulfonyl chloride
- 1427325-61-8/(1-Butylindol-3-yl)-(2-methylnaphthalen-1-yl)methanone
- 1012864-23-1/2-(Diethylamino)-N-(2,5-dimethylphenyl)acetamide hydrochloride